Nasdaq · Financials

UPEXI, INC. (UPXI)

As-reported financials and recent SEC filings for UPEXI, INC., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.

Snapshot

Revenue

$15.8M

Net income

$-13.7M

Net margin

-86.5%

Diluted EPS

$-1.73

ROE

-15.2%

P/E (TTM)

—

Market cap

—

Debt / equity

—

Income statement (as reported)

Line	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	$15.8M	$26.0M	$36.4M	$23.1M	$24.1M
Gross profit	$10.9M	$12.8M	$21.0M	$14.9M	$11.9M
Operating income	$-12.5M	$-22.5M	$-12.3M	$-6.5M	$1.4M
Net income	$-13.7M	$-23.7M	$-17.5M	$-2.0M	$3.0M
Diluted EPS	$-1.73	$-2.88	$-2.37	$-0.97	$0.47

Source: company XBRL financial statements on SEC EDGAR.

Recent SEC filings

S-32026-07-06

8-K2026-06-30

D2026-06-29

8-K2026-06-26

8-K2026-06-25

8-K2026-06-24

8-K2026-06-16

SCHEDULE 13G/A2026-05-15

View on EDGAR →

Largest Financials peers

BERKSHIRE HATHAWAY INC

$247.24B revenue

ELV

Elevance Health, Inc.

BANK OF AMERICA CORP /DE/

All Financials companies →

Go deeper on UPXI

Search UPEXI, INC.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.

Start free

Or check your whole portfolio free — no account needed.

Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.